Research Paper Volume 12, Issue 19 pp 19022—19044

Target RNA modification for epigenetic drug repositioning in neuroblastoma: computational omics proximity between repurposing drug and disease

class="figure-viewer-img"

Prognostic RNA modification regulators (RNA-MRs) and their prognostic values. Prognostic RNA-MRs had a P<0.05 in univariate Cox regression analyses (A) and LASSO analysis (B, C). The riskScore calculated using prognostic RNA-MRs generated a convinced ROC curve (D, E).